Last updated on January 2019

Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis


Brief description of study

The purpose of this study is to compare the safety and efficacy of secukinumab monotherapy and adalimumab monotherapy in patients with active psoriatic arthritis who are nave to biologic therapy and are intolerant or having inadequate response to conventional DMARDs

Clinical Study Identifier: NCT02745080

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Tel Aviv, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Kfar Saba, Israel
1.9miles
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ramat Gan, Israel
2.78miles
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Petach Tikva, Israel
6.21miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.